MARC details
000 -LEADER |
fixed length control field |
01857cam a22004094a 4500 |
001 - CONTROL NUMBER |
control field |
P 1200 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20140212102803.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
050614s2006 njua b 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2005017065 |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
Record control number |
101267017 |
Source |
DNLM |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
1588295648 (alk. paper) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)ocm60651107 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
Transcribing agency |
DLC |
Modifying agency |
YDX |
-- |
BAKER |
-- |
VAM |
-- |
CUX |
-- |
NLM |
-- |
MUQ |
-- |
DLC |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RC271.I45 |
Item number |
I45-2006 |
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
2006 B-494 |
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QZ 266 |
Item number |
I33 2006 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
616.99/4061 |
Edition number |
22 |
245 00 - TITLE STATEMENT |
Title |
Immunotherapy of cancer / |
Statement of responsibility, etc |
edited by Mary L. Disis. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Totowa, N.J. : |
Name of publisher, distributor, etc |
Humana Press, |
Date of publication, distribution, etc |
c2006. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xii, 516 p. : |
Other physical details |
ill. ; |
Dimensions |
26 cm. |
490 0# - SERIES STATEMENT |
Series statement |
Cancer drug discovery and development |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
505 ## - FORMATTED CONTENTS NOTE |
Formatted contents note |
Discovery of target molecules for cancer immunotherapy by genetic and bioinformatic approaches -- Current strategies for the identification of immunogenic epitopes of tumor antigens -- Current and future role of natural-killer cells in cancer im |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Antineoplastic agents |
General subdivision |
Design. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Cancer |
General subdivision |
Immunotherapy. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Neoplasms |
General subdivision |
immunology. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Neoplasms |
General subdivision |
therapy. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Immunotherapy. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Disis, Mary L. |
856 41 - ELECTRONIC LOCATION AND ACCESS |
Materials specified |
Table of contents |
Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/toc/ecip0514/2005017065.html">http://www.loc.gov/catdir/toc/ecip0514/2005017065.html</a> |
856 42 - ELECTRONIC LOCATION AND ACCESS |
Materials specified |
Publisher description |
Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/enhancements/fy0825/2005017065-d.html">http://www.loc.gov/catdir/enhancements/fy0825/2005017065-d.html</a> |
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
a |
7 |
b |
cbc |
c |
orignew |
d |
1 |
e |
ecip |
f |
20 |
g |
y-gencatlg |
925 0# - |
-- |
acquire |
-- |
2 shelf copies |
-- |
policy default |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Book |
955 ## - COPY-LEVEL INFORMATION (RLIN) |
-- |
jc01 2005-06-14 |
-- |
jc41 2005-06-14 |
-- |
jc14 2006-07-06 Z-CipVer |
-- |
jc14 2006-07-06 to BCCD |